[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

about

Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease.Behcet's disease: systemic and ocular manifestations.

P2860

Q35001001-A649B341-13F5-45BC-A0FA-8744D3518622 Q42181745-38FD2F3D-F682-453F-AC58-22687B4B22AD

P2860

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

Item

http://www.wikidata.org/entity/Q44524653

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@en

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@nl

type

Item

label

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@en

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@nl

prefLabel

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@en

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@nl

P1476

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

@en

P2093

D Hazirolan

http://www.w3.org/2001/XMLSchema#string

N Stübiger

http://www.w3.org/2001/XMLSchema#string

S Winterhalter

http://www.w3.org/2001/XMLSchema#string

U Pleyer

http://www.w3.org/2001/XMLSchema#string

P2860

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

A double-blind trial of colchicine in Behçet's syndrome

Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease.

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.

Behçet's disease: ocular effects and treatment.

A controlled trial of azathioprine in Behçet's syndrome.

High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease

Anti-TNF-alpha therapy for sight threatening uveitis.

The use of interferon alpha in Behçet disease: review of the literature.

P2888

s00347-012-2780-z

P304

273-284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00347-012-2780-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23504099

http://www.w3.org/2001/XMLSchema#string

P921

Behcet's disease

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

about

P2860

P2860

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921